Rare diseases
Investigational molecules
Locations
Back to Hungary346 clinical trials in Pecs, Hungary across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study of Brenipatide (LY3537031) in Adults with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
HungaryA Phase 3 Randomized Study of mRNA‑4157 plus Pembrolizumab as Adjuvant Therapy in Patients with Completely Resected Stage I Non‑Small Cell Lung Cancer
HungaryStudy of PF-07275315 versus placebo for efficacy and safety in adults with moderate-to-severe chronic obstructive pulmonary disease (COPD)
HungaryLong-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa
HungaryStudy to evaluate the long-term safety and effectiveness of lunsekimig in adults with moderate to severe asthma
HungaryPhase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC
HungaryStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
HungaryStudy of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo
HungaryStudy of AZD6793 tablets to reduce flare-ups in adults with moderate to very severe chronic obstructive pulmonary disease (COPD)
HungaryStudy of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease
HungaryStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
HungaryStudy of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis
HungaryThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on innovative treatments for chronic rhinosinusitis and asthma, with studies evaluating new therapeutic approaches for both conditions with and without nasal polyps.
Multiple trials investigating novel medications to improve respiratory symptoms and patient quality of life.
Groundbreaking studies in heart failure prevention and cardiomyopathy, exploring new therapeutic options for various cardiovascular conditions.
Advanced research aimed at reducing cardiovascular events and improving patient outcomes.
Innovative research into treatments for systemic sclerosis and Sjögren's syndrome, focusing on novel therapeutic approaches for these challenging conditions.
Studies evaluating new biological treatments to address various autoimmune conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
